This recording is from the first session of Xstrahl's 2021 clinical symposia, Radiotherapy for Benign Conditions. https://vimeo.com/710910255
Radiotherapy for Inflammatory Conditions
read more
Resources
Radiotherapy for Benign Disease: Assessing the Risk of Radiation-Induced Cancer
Low Dose Radiation Therapy for COVID-19: Effective Dose and Estimation of Cancer Risk
Cancer Risk after Radiotherapy for Benign Diseases
SARRP used in Combination Therapy Tumor Suppression
The below graphic displays highlights from the study, "Synergistic Anticancer Activity of N-Hydroxy-7-(2-Naphthylthio Heptanomide, Sorafenib, and Radiation Therapy in Patient-Derived Anaplastic Thyroid Cancer Models" by HJ Yun, HJ Kim, J Kim, SY Kim, HS Chang, CS...
SARRP Enables Targeted Focal Irradiation
This data comes from the presentation, "Radiation Enhances Anti-Tumor Activity of Checkpoint Blockade in Syngeneic Tumor Models" by Covance researchers Sumithra Urs, Mary Anne Meade, Kevin Guley, Sarah Krueger, Alden Wong, Scott Wise, and Maryland Rosenfeld Franklin....
Preclinical Dosimetry in Radiation Research
Precise, consistent dosimetry is crucial for accurate, repeatable research. Here at Xstrahl, we strive to offer researchers all of the tools and support you need to ensure accurate radiation dosage. Learn how we are doing that with our research systems and support...
SARRP Used on Intradermal Melanoma Tumor Model
Earlier this year, researchers identified a new intradermal melanoma model for melanoma immunotherapy combination studies, the Cloudman S91. The article, "Cloudman S91 – a responsive syngeneic melanoma model" by Sumithra Urs, PhD, Senior Scientist, Scientific...
Choosing the Best Radiotherapy Machine for Your Practice
Learn which Xstrahl system is best for you based on your practice's needs. See a detailed comparison of our radiotherapy systems at https://xstrahl.com/medical-system-comparison-chart/ https://vimeo.com/711330808
Contact Us